Associated Papers
Anti-Ku alloimmunization due to a KEL*02N.19 allele causing Kell-null phenotype despite KEL*02 genotype prediction.
Dara RC et al.
Vox Sanguinis, 2026
A novel KEL null allele with c.223+1g>t leads to the absence of the Kpb antigen in a First Nation donor.
Leiva-Torres GA et al.
Transfusion, 2021
Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
Williams EA et al.
Acta Neuropathologica Communications, 2020
33087175 (PubMed )
Supplement: 40478_2020_1040_MOESM1_ESM.xlsx › Sheet1
Low-Frequency Blood Group Antigens in Switzerland.
Gassner C et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie, 2018
Clinical Significance of an Alloantibody against the Kell Blood Group Glycoprotein.
Mattaloni SM et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie, 2017
Novel alleles at the Kell blood group locus that lead to Kell variant phenotype in the Dutch population.
Ji Y et al.
Transfusion, 2015
Molecular Basis of KELnull Phenotype in Brazilians.
Boturão-Neto E et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie, 2015
Identification of novel silent KEL alleles causing KEL:-5 (Ko) phenotype or discordance between KEL:1,-2 phenotype/KEL*01/02 genotype.
Martin-Blanc S et al.
Transfusion, 2013
Genetic diversity of KELnull and KELel: a nationwide Austrian survey.
Körmöczi GF et al.
Transfusion, 2007
Select a paper to view details